# 42 CFR Part 428, Subpart B—Determination of Part D Rebatable Drugs

42 CFR Part 428, Subpart B—Determination of Part D Rebatable Drugs, “Determination of Part D Rebatable Drugs”, is a CFR division of [42 CFR Part 428—Medicare Part D Drug Inflation Rebate Program](https://ontology.bommaritollc.com/id/01a0f0b4-2c85-77e9-adf9-e20b95824ab7).

IRI: <https://ontology.bommaritollc.com/id/01a0f0b4-288d-7726-8646-e412fea32404>

Within: [Title 42—Public Health](https://ontology.bommaritollc.com/id/01a0f0b4-250a-76eb-a6f4-ef896ca65429) › [42 CFR Chapter IV—CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f0b4-26ab-75ee-82a3-d67c7d7493e9) › [42 CFR Chapter IV, Subchapter B—MEDICARE PROGRAM](https://ontology.bommaritollc.com/id/01a0f0b4-26d0-77b0-a9cc-8ca65af16a4c) › [42 CFR Part 428—Medicare Part D Drug Inflation Rebate Program](https://ontology.bommaritollc.com/id/01a0f0b4-2c85-77e9-adf9-e20b95824ab7)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-division 42 CFR Part 428, Subpart B](https://ontology.bommaritollc.com/id/01a0f0b4-288e-7462-a9ec-dda4f6913a74)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title42-vol1](https://ontology.bommaritollc.com/id/01a0f0b4-288d-7726-8646-e41102166de8)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0b4-5c95-7136-ac5d-1797bd028599)
- `schema:isPartOf`: [42 CFR Part 428—Medicare Part D Drug Inflation Rebate Program](https://ontology.bommaritollc.com/id/01a0f0b4-2c85-77e9-adf9-e20b95824ab7)
- `schema:legislationIdentifier`: 42 CFR Part 428, Subpart B
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationType`: [CFR division](https://ontology.bommaritollc.com/vocab/leg/cfrDivision)
- `schema:name`: Determination of Part D Rebatable Drugs
- `skos:prefLabel`: 42 CFR Part 428, Subpart B—Determination of Part D Rebatable Drugs

## Elsewhere

- [Source](https://www.govinfo.gov/app/details/CFR-2025-title42-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Parts (2; `schema:isPartOf`):
  - [42 CFR 428.100 Definitions.](https://ontology.bommaritollc.com/id/01a0f0b4-49c0-7665-b27c-753338d85258)
  - [42 CFR 428.101 Identification of Part D rebatable drugs.](https://ontology.bommaritollc.com/id/01a0f0b4-49c1-765f-8744-063e522fd9bd)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f0b4-288d-7726-8646-e412fea32404.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f0b4-288d-7726-8646-e412fea32404.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f0b4-288d-7726-8646-e412fea32404.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f0b4-288d-7726-8646-e412fea32404)
Cite as: 42 CFR Part 428, Subpart B—Determination of Part D Rebatable Drugs. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f0b4-288d-7726-8646-e412fea32404
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
